Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valter Torri

Showing results (81-90 of 228) with videos related to

Pageof 23
Sort By:
Journal of the National Cancer Institute|October 2, 2003
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancerGiorgio V Scagliotti, Roldano Fossati, Valter Torri, et al.
Scientific Reports|February 22, 2020
Author Correction: Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma StudyEliana Rulli, Luciano Quaranta, Ivano Riva, et al.
Cancer|August 14, 2002
HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survivalGiovanni Selvaggi, Giorgio V Scagliotti, Valter Torri, et al.
Tumori|March 15, 2008
An oxaliplatin + 5-fluorouracil bolus + folinic acid (BFOL) regimen as first-line treatment in metastatic colorectal cancer patientsNicla La Verde, Marina Garassino, Claudia Bareggi, et al.
Clinical and Translational Radiation Oncology|March 20, 2025
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trialDario Valcarenghi, Angela Tolotti, Hansjoerg Vees, et al.
Oncology|September 6, 2007
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter studyMarina E Cazzaniga, Luigi Dogliotti, Stefano Cascinu, et al.
Journal of the National Cancer Institute|March 22, 2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]Federica Polato, Paolo Rusconi, Stefano Zangrossi, et al.
American Journal of Ophthalmology|December 3, 2014
Predictive value of heidelberg retina tomograph parameters for the development of glaucoma in the European glaucoma prevention studyStefano Miglior, Thierry Zeyen, Esther M Hoffmann, et al.
Cancer Treatment Reviews|February 18, 2014
Efficacy of biological agents in metastatic triple-negative breast cancerAnnalisa Bramati, Serena Girelli, Valter Torri, et al.
Radiology|March 6, 2009
High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteriaSilvia Stacchiotti, Paola Collini, Antonella Messina, et al.
Pageof 23

Showing results (81-90 of 228) with videos related to

Sort By:
Pageof 23
Journal of the National Cancer Institute|October 2, 2003
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancerGiorgio V Scagliotti, Roldano Fossati, Valter Torri, et al.
Scientific Reports|February 22, 2020
Author Correction: Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma StudyEliana Rulli, Luciano Quaranta, Ivano Riva, et al.
Cancer|August 14, 2002
HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survivalGiovanni Selvaggi, Giorgio V Scagliotti, Valter Torri, et al.
Tumori|March 15, 2008
An oxaliplatin + 5-fluorouracil bolus + folinic acid (BFOL) regimen as first-line treatment in metastatic colorectal cancer patientsNicla La Verde, Marina Garassino, Claudia Bareggi, et al.
Clinical and Translational Radiation Oncology|March 20, 2025
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trialDario Valcarenghi, Angela Tolotti, Hansjoerg Vees, et al.
Oncology|September 6, 2007
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter studyMarina E Cazzaniga, Luigi Dogliotti, Stefano Cascinu, et al.
Journal of the National Cancer Institute|March 22, 2014
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]Federica Polato, Paolo Rusconi, Stefano Zangrossi, et al.
American Journal of Ophthalmology|December 3, 2014
Predictive value of heidelberg retina tomograph parameters for the development of glaucoma in the European glaucoma prevention studyStefano Miglior, Thierry Zeyen, Esther M Hoffmann, et al.
Cancer Treatment Reviews|February 18, 2014
Efficacy of biological agents in metastatic triple-negative breast cancerAnnalisa Bramati, Serena Girelli, Valter Torri, et al.
Radiology|March 6, 2009
High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteriaSilvia Stacchiotti, Paola Collini, Antonella Messina, et al.
Pageof 23